Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Rheumatoid arthritis‐associated interstitial lung disease (RA‐ILD) is an irreversible pathologic condition of unknown cause, commonly involving the joint and the lung with variable amounts of fibrotic change. In contrast to rheumatoid arthritis or other chronic interstitial lung diseases such as interstitial pulmonary fibrosis, there is so far no extensively accepted or implemented animal model for this disease.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Aims</h3><p>To provide guidance for those who are investigating the pathogenesis of RA‐ILD with animal models.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Materials and Methods</h3><p>An analysis of papers from PubMed during 1978‐2020.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>We outline the present status quo for animal models of RA‐ILD about their modeling methods and pathogenesis, compare their pros and cons with respect to their ability to mimic the clinical and histological features of human disease and discuss their applicability for future research.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Discussion</h3><p>There is no doubt that these animal models do provide valuable information relating to the pathogenesis of RA‐ILD and the development of effective therapeutic drugs. Nevertheless, these animal models can not entirely recapitulate clinical pathology and have some limitations in experimental research application. Therefore, it should be emphasized that we should improve and explore animal models in more accordance with the pathogenesis and clinical characteristics of human RA‐ILD.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>These established animal models of the disease can significantly progress our understanding of the etiology of RA‐ILD, the fundamental mechanisms of its pathogenesis and the identification of new bio‐markers, and can contribute to the development and implementation of novel treatment strategies.</p></section>

The establishment of a rheumatoid arthritis primate model in Macaca fascicularis

The establishment of a rheumatoid arthritis primate model in Macaca fascicularis

Modeling human arthritic diseases in nonhuman primates

Experimental animal models for rheumatoid arthritis

Establishment of the animal model of experimental autoimmune myositis

Emerging Landscape of In Vitro Models for Assessing Rheumatoid Arthritis Management

Central Role of RIPK1-VDAC1 Pathway on Cardiac Impairment in a Non-Human Primate Model of Rheumatoid Arthritis.

Collagen-induced arthritis in common marmosets: a new nonhuman primate model for chronic arthritis

Modelling rheumatoid arthritis: A hybrid modelling framework to describe pannus formation in a small joint

Therapeutic effects of anti-CD154 antibody in cynomolgus monkeys with advanced rheumatoid arthritis

Latest models for the discovery and development of rheumatoid arthritis drugs

Generation of a robust model for inducing autoimmune arthritis in Sprague Dawley rats

Animal models of rheumatoid arthritis‐associated interstitial lung disease

Alteration of the gut microbiota in rhesus monkey with spontaneous osteoarthritis

Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis

The promise of Synovial Joint-on-a-Chip in rheumatoid arthritis

Novel mechanistic study of HDAC6 regulation of rheumatoid arthritis via CMA: exploring potential therapeutic targets

Selection and Investigation of a Primate Model of Spontaneous Degenerative Knee Osteoarthritis, the Cynomolgus Monkey (Macaca Fascicularis)

Synovial joint-on-a-chip for modeling arthritis: progress, pitfalls, and potential

CRISPRa Engineered Elite Macrophages Enable Adoptive Cell Therapy for Rheumatoid Arthritis

Pain pathogenesis in rheumatoid arthritis -- what have we learned from animal models